Loading clinical trials...
Loading clinical trials...
Developmental Pathways to Health and Disease: Metabolic, Neurodevelopmental and Related Outcomes
This study aims to examine the role of genetic and epigenetic factors, maternal nutrition, lifestyle, emotional health, and other environmental factors in pregnancy or postpartum period that can influence future maternal risk of metabolic and mental wellness, including body weight changes. The study will recruit women in early pregnancy and later follow their children after birth, tracking both the mother and child until the child reaches at least 20 years of age.
The dramatic emergence of non-communicable diseases (NCDs) in Asia has coincided with the rapid socioeconomic and nutritional transition taking place in the region, with the prevalence of diabetes rising five-fold in Singapore in less than four decades. One unique aspect of the epidemic has been the significant ethnic differences in predisposition to diabetes among Asians and in the ethnic variation between BMI and the risk of developing insulin resistance, a precursor to type 2 diabetes. Apart from genetic factors, dietary, lifestyle and cultural factors might have influenced the developmental programming through effects on the mechanisms associated with developmental plasticity. A center piece of this study is to examine how epigenetic changes at birth both reflects past developmental influences and, in association with other factors, influences future trajectories of development and its relationship to NCDs. Also factors active during childhood - especially the first 1000 days of life - will be focused upon. The longitudinal GUSTO birth cohort study allows us to examine associations among genetic, environmental and lifestyle interactions in the three distinct ethnic groups, Chinese, Malays and Indians, present in the Singaporean population. Participants have been followed up for their pregnancy outcome, fetal growth and offspring development. In continuation of this research, participants will continue to be followed up through their adolescence phase from the age of 10 to 20 years. Data will be collected through questionnaires and measurements. * Questionnaires may be related to socioeconomic factors, healthcare expenses, diet, medical history, behaviour, cognition, lifestyle, sleep, health status, social-emotion factors, and home environment. * Body measurements such as height, weight, blood pressure, body composition analysis involving bioelectrical impedance analysis (BIA), grip strength. * Dental examination * Child pubertal assessments * Skin clinical assessment and digital photography for assessment of acne presence and severity * Monitoring physical activity level and sedentary behaviour by using an accelerometer * Using mobile phone app to collect information about your child's mobile phone usage patterns, activities etc. * Collection of samples e.g. blood, buccal swabs, saliva, hair, urine, stool, skin samples, oral specimen such as exfoliated milk teeth, dental plaque and tongue biofilms
Age
All ages
Sex
ALL
Healthy Volunteers
Yes
National University Hospital
Singapore, Singapore, Singapore
Start Date
June 1, 2009
Primary Completion Date
July 1, 2029
Completion Date
July 1, 2029
Last Updated
February 9, 2026
1,247
ACTUAL participants
Lead Sponsor
National University Hospital, Singapore
Collaborators
NCT07420023
NCT05236374
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06089421